OneMedNet Delivers Anonymized Real-World Data Feed to Healthcare Analytics Organization

Reuters01-16
<a href="https://laohu8.com/S/ONMD">OneMedNet</a> Delivers Anonymized Real-World Data Feed to Healthcare Analytics Organization

OneMedNet Corporation announced the successful delivery of an anonymized Real-World Data feed representing 1.5 million patients and 4 million encounters to a healthcare data and analytics organization serving pharmaceutical, biotechnology, and medical device companies. The data feed was provided under OneMedNet's subscription model and is intended to support enterprise-scale testing and validation of the recipient’s platform. The dataset includes over 1.49 billion datapoints of structured and unstructured data, covering a broad range of clinical information. The delivery enables the recipient to ingest, harmonize, and operationalize complex healthcare data for production deployment and commercial scale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9627131-en) on January 16, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment